Showing results (111-120 of 194) with videos related to

Sort By:
Pageof 20
Molecular Pharmaceutics|August 26, 2020
Application of a Scavenger Receptor A1-Targeted Polymeric Prodrug Platform for Lymphatic Drug Delivery in HIVDavid M Stevens, Pavan Adiseshaiah, Siva S K Dasa, et al.
Plos Pathogens|February 6, 2014
Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administrationIrini Sereti, Jacob D Estes, William L Thompson, et al.
Open Forum Infectious Diseases|December 10, 2021
A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral TherapyRachel M Presti, Eunice Yeh, Brett Williams, et al.
Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians|December 30, 2011
Pathologic lesions in chimpanzees (Pan trogylodytes schweinfurthii) from Gombe National Park, Tanzania, 2004-2010Karen A Terio, Michael J Kinsel, Jane Raphael, et al.
The Journal of Clinical Investigation|May 24, 2008
Availability of activated CD4+ T cells dictates the level of viremia in naturally SIV-infected sooty mangabeysNichole R Klatt, Francois Villinger, Pavel Bostik, et al.
Plos Pathogens|March 29, 2023
Chronic immune activation and gut barrier dysfunction is associated with neuroinflammation in ART-suppressed SIV+ rhesus macaquesSarah J Byrnes, Kathleen Busman-Sahay, Thomas A Angelovich, et al.
Clinical and Vaccine Immunology : CVI|September 23, 2016
Balancing Trained Immunity with Persistent Immune Activation and the Risk of Simian Immunodeficiency Virus Infection in Infant Macaques Vaccinated with Attenuated Mycobacterium tuberculosis or Mycobacterium bovis BCG VaccineKara Jensen, Myra Grace Dela Pena-Ponce, Michael Piatak, et al.
Journal of Virology|May 20, 2011
One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidatesPaul W Denton, Florence Othieno, Francisco Martinez-Torres, et al.
Plos Pathogens|May 5, 2017
Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapyChristine M Fennessey, Mykola Pinkevych, Taina T Immonen, et al.
Plos Pathogens|October 31, 2014
CD4 depletion in SIV-infected macaques results in macrophage and microglia infection with rapid turnover of infected cellsLuca Micci, Xavier Alvarez, Robin I Iriele, et al.
Pageof 20